Living with Type 1 diabetes requires constant monitoring of blood sugar levels and injecting insulin daily. Now scientists are reporting in the ACS journal Industrial & Engineering Chemistry Research the development of an implantable “artificial pancreas” that continuously measures a person’s blood sugar, or glucose, level and can automatically release insulin as needed.
Type 1 diabetes, previously known as juvenile diabetes, affects about 1.25 million Americans. About 200,000 of them are under 20 years old. The condition arises when a person’s own immune system destroys the pancreas cells that make insulin, the hormone that converts blood sugar into energy. To make up for this loss of insulin production, patients must take insulin daily. Current delivery methods involve multiple daily injections or insulin pump therapy, both requiring the user to actively track glucose and calculate the needed insulin dose. There is also a significant time lag between when a dose is needed and when it can take effect. Francis J. Doyle III and colleagues wanted to find a way to make monitoring and insulin delivery automatic and needle-free.
The researchers designed an algorithm that monitors blood sugar levels and computes an insulin dose that it delivers quickly and automatically when necessary. The algorithm is designed to work with implanted devices, specifically with an artificial pancreas, and would overcome the delays experienced with current devices. Computer testing of the algorithm simulated the rise and fall of glucose that would correspond to meals and an overnight period of sleep. The artificial pancreas maintained blood glucose within the target range nearly 80 percent of the time. The researchers say they will soon test the device in animals.
The Latest on: Diabetes
via Google News
The Latest on: Diabetes
- Horizon BCBSNJ members can use mobile glucose monitors to manage diabeteson January 24, 2020 at 12:29 pm
Horizon Blue Cross Blue Shield of New Jersey will give members more tools to monitor diabetes with cell phones, under an agreement with Livongo, provider of a chronic condition management platform.
- Yeast Reveal Insights into Type 2 Diabeteson January 24, 2020 at 12:12 pm
Arsenic is a common contaminant in water. Epidemiological studies report a connection between arsenic exposure and type 2 diabetes. In contrast to Type 1 diabetes in which the cells that make insulin ...
- Saying ‘diabetes doesn’t discriminate,’ Gov. J.B. Pritzker signs measure limiting out-of-pocket cost of insulin to $100 for 30-day supplyon January 24, 2020 at 12:06 pm
Illinois became one of the first states in the U.S. to limit the out-of-pocket price of insulin when Gov. J.B. Pritzker signed a measure on Friday that caps the cost of medication people with diabetes ...
- Diabetes Care from Licking Memorial Health Systemson January 24, 2020 at 11:07 am
At this moment more than 30 million people in the United States have diabetes. And one in four have no idea they have it. These stats are staggering and because of it’s prevalence, Licking Memorial is ...
- Can you ‘catch’ heart disease, cancer, and diabetes?on January 24, 2020 at 10:46 am
A recent paper outlines an intriguing new theory. The authors ask whether the microbes that inhabit the human body could transfer diseases such as diabetes and heart disease from person to person.
- European Diabetes Market Report 2019 to 2025 - Covering Diabetes Monitoring, Treatment & Drug Delivery - ResearchAndMarkets.comon January 24, 2020 at 8:14 am
DUBLIN--(BUSINESS WIRE)--The "Diabetes Market Analysis, Size, Trends | Europe | 2019-2025" report has been added to ResearchAndMarkets.com's offering. This report covers the European market for ...
- Ketosis more likely in type 2 diabetes with elevated osteocalcin levelson January 24, 2020 at 5:33 am
Adults with type 2 diabetes and lower levels of osteocalcin may be more likely to experience ketosis compared with those with higher levels, according to findings published in Diabetes/Metabolism ...
- Let's Talk About Type 2 Diabeteson January 23, 2020 at 9:23 pm
It’s hard to say there’s “good news” about any disease diagnosis, but if there’s a silver lining with type 2 diabetes, it’s this: You are very much in control of your destiny. Type 2 diabetes can ...
- Diabetes Insulin Pen Market 2019-2026 | In Depth Analysis on Growth, Trends, and Business Outlookon January 23, 2020 at 9:04 pm
The recently published report titled "Global Diabetes Insulin Pen Market: Global Industry Size, Share, Trends and Forecast, 2019-2026" Industry 2019 Market Research Report is an in depth study ...
- Rising obesity, diabetes affects CVD burden in Europeon January 23, 2020 at 7:33 am
The prevalence of obesity and diabetes across 56 European Society of Cardiology member countries has increased two- to threefold in 30 years, hampering efforts to reduce CVD burden, according to the ...
via Bing News